Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
they actually lose muscle mass and bone mass, which could help explain the association
A 2007 double-blind, multicenter trial (n=102) showed ALC 1,500 mg/day significantly improved tender point count, total myalgic score, depression, and musculoskeletal pain compared to placebo.[9] A 2015 RCT found ALC 1,500 mg/day comparable to duloxetine 60 mg/day for pain and depression.[8] Most notably, a 2023 RCT demonstrated that adding PEA 1,200 mg/day + ALC 2,000 mg/day to ongoing duloxetine + pregabalin therapy produced significantly greater improvements in Widespread Pain Index, FIQR, and FASmod scores.[7] Role in Treatment: ALC can be used as monotherapy or adjunctive therapy in fibromyalgia
Patients with favorable genetic markers often achieve target weight loss faster and with fewer side effects
For more detailed insights on how BPC-157 functions, especially its implications for overall health and its mechanisms at the cellular level, consider referring to these discussions from the Mind Pump Podcast episodes and clips
.png)
